The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast | Physical Activity in CKD patients: time to overcome nephrologist’s inertia

Physical Activity in CKD patients: time to overcome nephrologist’s inertia